Herpes Cure And Treatment

Latest Cold Sore Research

Update on HSV Research. We have recently extended our efforts to cure HSV infections by developing DNA editing enzymes as potential HSV treatments. Net – Latest Medical News and Research from Around the World. Read the latest research on the herpes virus, including new treatment options. Cold Sores Increase Risk of Dementia, Research Suggests. Oct. 20, 2014.

Cold sores have been described for thousands of years and it is said that the Roman Emperor Tiberius banned kissing because so many people were affected by the problem. The new research suggests that cold sores might be controlled using specific medicines. Latest news and research breakthroughs on Cold Sores. Last updated on May 27, 2015 with over 77 News and research items available on the subject. Due to the genetic similarity of both herpes simplex virus types (HSV-1 and HSV-2) , the development of a prophylactic-therapeutic vaccine which is proven effective against one type of the virus would provide fundamentals for vaccine-development for the other virus type. However, governmental and corporate bodies seem to support the more recent but possibly less effective approaches such as Glycoprotein and DNA based vaccines.

Cold Sores New News For An Old Problem

Discuss the latest developments and what is being done RIGHT NOW to bring an end to herpes. Promising research from Australia targeting Hep B may also rid hsv. Researchers in Canberra have discovered the herpes virus remains active in the body even when there are no symptoms, potentially opening the door to new treatments and clues as to why cold sore flare up sporadically and why some infected people never get them. New research offers insight into cold sore virus. LATEST VIDEO. New thinking about vaccine design has helped researchers forge ahead in developing a potential vaccine. Current estimates suggest that 500 million people worldwide are infected with HSV-2, with approximately 20 million new cases occurring annually.

Researchers Negar Talaei Zanjani and Dr Peter Valtchev study cold sores virus. The blue blood of abalone, a seabed delicacy could be used to combat common cold sores and related herpes virus following breakthrough research at the University of Sydney. The first vaccine to protect against the herpes virus that causes cold sores could soon be on the market. It has already been successfully tested on hundreds of women to protect against a different form of the virus, and researchers found it prevented seven out of ten being infected by a partner. Cold sores, members of the herpes family of viruses, are an unpleasant fact of life for millions of people in the UK, with the latest research estimating that between 25pc and 45pc of adults have several attacks a year. At least 20 of patients with HSV experience recurring cold sores. In addition, recent studies have shown that using valacyclovir before certain dental procedures can help decrease recurrent outbreaks. Some research demonstrates that penciclovir appears to reduce the average size and duration of a cold sore.

Study: New Way To Hold Back Herpes, Keep Virus Latent

It’s a tactic that researchers say may also hold promise for attacking HIV, another virus whose habit of hiding out makes it hard to kill, and the herpes zoster virus that causes excruciating shingles. Herpes viruses are best known for causing cold sores and genital lesions but they can also affect the eye, potentially leading to blindness. A new study finds that state-level efforts to increase organ donations over recent decades have made barely a dent in the shortage so should we think seriously about paying donors big bucks? Researchers have discovered how the cold sore virus hides in the body, which may be the key to a permanent cure. Presently, the most effective treatment for cold sores is through using creams containing the anti-viral acyclovir. Application of this medication halts the progression of the signs and symptoms but does not kill the virus. Recent Posts. TRACY McDONNELL’S life was blighted by cold sores until she stumbled on a very unexpected cure. Research suggests some people may have a genetic defect that means they do not produce a protein which stops the virus reactivating. (National Institute of Dental and Craniofacial Research). Current research on the whether antiviral creams and sunscreen can prevent cold sores is contradictory based on several trials, according to the Canadian Family Physician article. Org, Mayo Clinic Healthy Living, and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research. The cold, hard reality of biomedical research is that ideas are cheap and plentiful, while the process required to transfer those ideas to the clinic is long, risky and extremely expensive. The pharmaceutical firm GlaxoSmithKline (GSK) makes an over-the-counter product called Abreva, which is the only FDA-approved topical treatment currently available for cold sores. Recent advances in cancer research have accelerated the push toward new drugs targeted at specific genetic mutations and signaling defects that trigger the development of malignant tumors. HSV-2 is a lifelong and incurable infection that can cause recurrent and painful genital sores and can make those infected with the virus two-to-three times more likely to acquire HIV, the virus that causes AIDS. The latest study is the largest ever randomised trial of an anti-cancer virus and involved 436 patients from 64 centres in the US, the UK, Canada and South Africa who had inoperable malignant melanoma. Dr Hayley Frend, science information manager at Cancer Research UK, said: Previous studies have shown T-Vec could benefit some people with advanced skin cancer, but this is the first study to prove an increase in survival. In pre-clinical research, the drug was potent against HSV-1 and HSV-2 isolates and was efficacious in animals, while phase I trials in humans did not raise any safety concerns. Wald and colleagues noted in the journal that the animals were given very high doses – more than 70 times the 75-mg dose in the current study. Further research into the normal physiological functions of HSV receptors and ligands may allow rational prediction of the toxicities of vaccines or therapeutics directed at inhibiting HSV entry.


Real Time Web Analytics
Scroll To Top